Although it has been nearly 50 years since Stuart R. Weiss, M.D. ’71, graduated from the University of Miami School of Medicine, he is still dedicated to ensuring the future of his medical alma mater. Weiss, an endocrinologist, has been a generous supporter of the medical school for more than 40 years. His first gift to the school came just three years after graduation.
In hopes of finding new ways to potentially prevent the debilitating effects of arthritis in different regions of the ankle, Amiethab A. Aiyer, M.D., chief of the Foot & Ankle Service and assistant professor in the University of Miami Miller School of Medicine’s Division of Orthopaedic Surgery, recently received a prestigious research grant from the American Orthopaedic Foot & Ankle Society (AOFAS).
They say that whenever an angel gets its wings, a bell rings. The bell that Miami resident Jorge Bustamante heard in his head three years ago may well have been a sign that his beloved daughter, Mikaela, whose life ended far too soon, had gotten her wings. But it also signaled the genesis of an idea Jorge had that would turn anguish into action, and tragedy into tribute.
Sylvester Provides 100 Patients Potentially Life-Saving Treatments in its Phase 1 Trial Program 02.19.2018
Dr. Jaime Merchan is thrilled that Sylvester Comprehensive Cancer Center has reached the milestone number of 100 patients enrolled in a single year in its Phase 1 clinical trials program. The program, which tests new drugs and other novel treatment strategies for advanced solid tumors and hematological malignances, offers these patients something they couldn’t find elsewhere: hope.
New Analysis: Patients Receiving Chemo for Cancer at ADCC Institutions Have Highest Survival Rates 02.19.2018
Patients treated with chemotherapy for some of the most common types of cancer at Dedicated Cancer Centers have higher survival rates compared to patients treated at other types of hospitals, according to new analysis conducted by Milliman for the Alliance of Dedicated Cancer Centers. Sylvester Comprehensive Cancer Center is one of only 11 members of the Alliance of Dedicated Cancer Centers.
Sylvester Comprehensive Cancer Center has once again been recognized as a Cancer Center of Excellence by the State of Florida — one of just four cancer centers in the state, and the only one in South Florida, to have earned this honor. The designation recognizes providers that exceed service standards and excel in providing quality, comprehensive and patient-centered, coordinated care for cancer patients in Florida.
The UHealth Process Improvement Team is launching its first Process Improvement Showcase and welcomes individuals and teams from across the University of Miami Health System to participate. All students, faculty and staff are encouraged to get involved. The showcase allows for teams to display and share their process improvement success stories with colleagues from all areas of the health system.
Sarah Sukkar vividly remembers the phone call from the University of Miami Leonard M. Miller School of Medicine. At the other end of the phone, an admissions officer was telling her that not only had she been accepted into the medical school’s Class of 2020, but that she’d been awarded a scholarship too. The second-year M.D. candidate expressed her gratitude at the 2018 Medical Education Donors and Scholars Luncheon.
A collaborative U01 grant titled “Unifying Templates, Ontologies and Tools to Achieve Effective Annotation of Bioassay Protocols” has been awarded to the University of Miami together with Stanford University and Collaborative Drug Discovery. The principal investigators of this $2,088,678 U01 grant are Stephan Schürer of the UM Miller School of Medicine, Mark Musen of Stanford, and Barry Bunin at Collaborative Drug Discovery.
UM Researcher Joins New NIH Partnership to Promote Organization of Big Data in Biomedicine 02.14.2018
The University of Miami Miller School of Medicine is joining a partnership to combine advances in ontologies, templates and other research tools to take digital biomedical research data to the next level. The National Institutes of Health has awarded a $2,088,678 U01 grant to be shared under a cooperative agreement between Stephan Schürer, Ph.D., and colleagues at Stanford University and Collaborative Drug Discovery.